针对p53进行癌症治疗的天然产品
1Department of Natural Medicines, Graduate School of Pharmaceutical Sciences, Kumamoto University, 5-1 Oe-Honmachi, Kumamoto, 862-0973, Japan. sachiko@kumamoto-u.ac.jp.
Journal of natural medicines
|April 28, 2025
概括
自然产品可以通过抑制其降解和诱导形状变化来重新激活瘤抑制剂p53. 这种方法对开发针对p53-依赖增长抑制的新型癌症治疗有希望.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 自然产品 化学 化学
背景情况:
- 野生类型的p53是一种关键的瘤抑制剂,但其在癌症中经常发生的突变和失活会导致瘤的进展,入侵和转移.
- 重新激活p53是癌症治疗的有前途的治疗策略,目前正在进行药物开发工作.
- 以其结构多样性和生物活性而闻名的自然产品是治疗剂的宝贵来源.
研究的目的:
- 通过p53-Mdm2相互作用抑制p53降解的天然产品进行审查.
- 讨论通过结构变化促进p53活性化的天然产品.
- 突出显示p53-依赖增长抑制的天然产品用于癌症治疗.
主要方法:
- 关于天然产品和p53.53研究的文献综述.
- 分析涉及p53-Mdm2相互作用的机制.
- 研究自然产品诱导的p53.3的形状变化.
- 对p53依赖的增长抑制试验的评估.
主要成果:
- 通过向p53-Mdm2相互作用来抑制p53降解,已经确定了几种天然产品.
- 自然化合物显示出诱导形状变化的能力,导致p53的重新激活.
- 这些重新激活的p53分子表现出显著的p53-依赖性抑制癌细胞生长.
结论:
- 自然产品提供了一种可行的策略来重新激活瘤抑制剂p53.
- 针对p53-Mdm2相互作用和诱导构造变化是自然化合物对p53活性化的关键机制.
- 这些发现支持通过p53的重新激活来开发天然产品衍生疗法来治疗癌症.
更多相关视频
相关概念视频
Abnormal Proliferation
4.3K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.3K
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
The Intrinsic Apoptotic Pathway
5.5K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
5.5K
Negative Regulator Molecules
35.0K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.0K
Drugs that Stabilize Microtubules
1.9K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
1.9K
DNA Damage can Stall the Cell Cycle
9.0K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.0K


